Press Release November 30, 2005

CeNeRx Raises $18.5 Million

BOSTON, Nov. 30, 2005 – CeNeRx raised $18.5 million in a Series A round led by Perseus-Soros.  Other investors included L Capital Partners, A.M. Pappas & Associates, and Wistar Morris.  CeNeRx is developing reversible inhibitors of monoamine oxidase for depression and anxiety.

Lawrence Wittenberg, partner, and Danielle Lauzon, associate, represented Perseus-Soros in this transaction.